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Myopia is becoming increasingly prevalent throughout the world. It is an overlooked but 
leading cause of blindness, particularly among the working aged population. Myopia is often 
considered benign because it is easily corrected with glasses, contact lenses, or refractive 
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surgery.  Traditionally myopia has been classified into physiological and pathological 
subtypes based on the degree of myopia present. Higher levels of myopia are associated 
with increased risk of pathological complications but it is important to note that there is no 
safe level of myopia. Even low levels of myopia increase the risk of retinal detachment and 
other ocular comorbidities which will be discussed in detail later. The most serious 
complication, myopic maculopathy, is the only leading cause of blindness without an 
established treatment and therefore leads to inevitable loss of vision in some myopes, even 
at a young age. 
Aim: To highlight the current myopia epidemic and the sight threatening complications 
associated with it 
Design:  This is a comissioned review article. Data was gathered by performing a literature 
review, searching the PubMed database for recent articles regarding myopia. 
Conclusions:  Myopia is a potentially blinding disease. By identifying at risk individuals and 
intervening before they become myopic, eye care practitioners can prevent or delay 
spectacle use, reduce the risk of the myriad of myopic complications and thereby improve 














The concept of myopia originated with Aristotle (350 BC), who used the word μύώψς 
(muoops) derivated from μύειν (muein, to close) and ωψ (oops, the eye). 1 Around 1700, 
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increased ocular length was noted to be associated with myopia. 2  Theories about the 
condition continued to be developed throughout the 1800’s and beyond. 3 Myopia or 
nearsightedness occurs when parallel rays of light are focused in front of the retina 
rendering the patient unable to see in the distance. It can be defined, from an optical 
perspective, as a refractive anomaly of the non-accommodated eye which can be corrected 
using concave (negatively powered) lenses. It can also be defined physiologically, as an 
abnormality of eye growth resulting in excessive axial elongation of the eye.4 
Why is myopia important?  Firstly, the condition is becoming increasingly prevalent 
throughout the world; secondly, it is an overlooked but leading cause of blindness, 
particularly among the working aged population. Myopia is often considered benign 
because it is easily corrected with glasses, contact lenses, or refractive surgery.  Traditionally 
myopia has been classified into physiological and pathological subtypes based on the degree 
of myopia present. Higher levels of myopia are associated with increased risk of pathological 
complications but it is important to note that there is no safe level of myopia. Even low 
levels of myopia increase the risk of retinal detachment and other ocular comorbidities 
which will be discussed in detail later. The most serious complication, myopic maculopathy, 
is the only leading cause of blindness without an established treatment and therefore leads 
to inevitable loss of vision in some myopes, even at a young age. 
Prevalence 
Myopia is the most common ocular abnormality in the world. 5,6 With an estimated 1.406 
billion people with myopia (22.9% of the world population) and 163 million people with high 
myopia (2.7% of the world population) in the year 2000, the disorder has significant public 
healthcare implications worldwide, and poses a significant societal and economic burden to 
healthcare systems globally. 4 Current estimates predict that myopia and high myopia will 
significantly increase, to affect nearly 5 billion (50% of the projected global population), and 
1 billion respectively, in 2050. 6 
Rates as high as 96.5% have been reported in young males in South Korea.7 Its prevalence is 
increasing, not only in East Asian populations, but also in the West. 8, 9  Findings from the 
Northern Ireland Childhood Errors of Refraction (NICER) study show that nearly one in five 
teenagers in the UK are myopic, with myopia being more than twice as prevalent among UK 
children now than in the 1960’s (16.4% vs 7.2%). 10  Furthermore over 50% of British 
University students are myopic. 11  The figures for the Republic of Ireland are similar where 
the prevalence of myopia in children aged 12-13 years is 19.9%. 12  Within the United States 
myopia prevalence has doubled in just 30 years and now affects almost 1 in 2 people there. 
Furthermore, vision impairment in the US is projected to increase by 26% by 2060, with 
almost 70% of cases caused by refractive error. 13 Hence, the increasing prevalence of 





Figure 1. Regional prevalence of myopia and projected trends from 2000 through 2050 
(Data sourced from Holden et al.)6 
Risk factors for myopia development 
Myopia is likely due to a combination of environmental and genetic factors that influence 
the normal growth mechanisms of the eye. Genetic factors are well established as a cause of 
myopia. Although the specific genes and pathways are not yet fully defined, several genes 
have been identified that are associated with high myopia. There is also good evidence for 
gene-environment interactions. A recent study demonstrated that the impact of a specific 
gene (APLP2) on myopia was dependent on reading behaviour .14 
Analysis of syndromic forms of myopia has also recently provided novel insights into the 
genetics of myopia, with 21 novel candidate genes and genetic pathways identified, thereby 
providing further insights into the aetiology of myopia.15 Children with one myopic parent 
are almost three times more likely to be myopic by age 13 than a child without a myopic 
parent. This increases to over seven times more likely when both parents are myopic. 10  
It is now widely accepted, however, that environmental, lifestyle and behavioural factors 
are driving the current change in prevalence. Many epidemiological surveys have shown 
that excessive close-up work, a high level of education, and reduced participation in outdoor 
activities are important environmental risk factors for myopia.16, 17 A recent study using the 
technique of Mendelian Randomisation has provided clear evidence of a causal relationship 
between increased education and myopia.18 
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 More time spent outdoors and illiteracy have long been associated with a reduced 
incidence of myopia.19 Although twin studies show an apparent high heritability of refractive 
errors, the dramatic and precipitous recent changes in prevalence of myopia cannot be 
explained by changes in the gene pool. 20 People who are not genetically predisposed, it 
seems, are becoming myopic due to lifestyle and behavioural choices. 
Increasing urbanisation also appears to be a factor. A recently published systematic review 
examined the global variation of childhood myopia and found that children living in 
predominantly urban environments have 2.6 times the risk of myopia compared to children 
living in rural environments. 19 Potential explanations include a more congested 
environment, a greater emphasis on education, and as a result more near-vision work and 
fewer outdoor activities. In a study involving  863 Australian children, children who were 
myopic only spent an average of 16.3 hours outdoors per week compared to non-myopic 
children, who spent 21.0 hours outdoors. Children are now growing up in an era of visually 
demanding technology, this may be a factor as (a) it competes for leisure time that might 
otherwise be spent outdoors and (b) it involves extended periods of proximal viewing, often 
at very close proximity to the eyes, thereby contributing to two of the major risk factors for 
myopia development. Recent data in Ireland (as yet unpublished –abstract accepted for 
Association for Research in Vision and Ophthalmology conference, April 2019) revealed that 
myopic students use twice as much smartphone data as non-myopes. This evolving risk 
factor requires further exploration. 21 
Economic Burden 
As the prevalence of myopia is increasing dramatically, the large socio-economic costs 
associated with myopia make the disorder a serious public health issue. 22 The global 
productivity lost due to vision impairment caused by uncorrected refractive error is 
estimated to be $202 billion annually. 23 There are various other costs not included in these 
calculations, including the cost to government and affected individuals of treating myopia 
itself, the cost of treating the associated ocular co-morbidities and of managing vision 
impairment and blindness among those affected. The quality of life impact also needs to be 
considered in order to get a better indication of the true socio-economic impact of myopia.   
The public health and economic impact of myopia is extensive and comparable with other 
major chronic diseases, but crucially, given the nature of the causal mechanisms driving the 
epidemic, the impact is modifiable with suitable intervention. Thus, myopia warrants 
significantly more international attention as a global public health concern. 
Ocular comorbidities 
In addition to the costs of optical correction, high myopia is associated with significant 
ocular morbidity and visual disability. While glasses, contact lenses and refractive surgery 
can effectively address the symptoms of refractive error, myopic patients are at an 
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increased risk of numerous secondary sequelae including glaucoma, cataract, optic 
neuropathy, staphlyoma, retinal detachment and myopic macular degeneration. 24, 25,26  
The aforementioned conditions are potentially blinding. The impact of the rise in myopia 
prevalence is compounded by the fact that the prevalence rises are accompanied by an 
increase in the average magnitude of myopia, with children becoming myopic at a younger 
age and progressing faster to higher levels. As the level of risk is associated with the degree 
of myopia, this places those affected at higher risk of complications and vision loss. Already, 
in the working population in the UK, Ireland and Europe, myopia is among the leading 
causes of blindness and becoming a more significant concern. 27  
Myopia represents a major risk factor for ocular disease that is comparable, even for low to 
moderate levels of myopia, with the risks associated with hypertension for cardiovascular 
disease.20 The myopia risks for glaucoma and cataract are also comparable with the risks of 
stroke from smoking >20 cigarettes per day. For retinal detachment and myopic 
maculopathy, myopia carries a risk far in excess of any identified population risk factor for 
cardiovascular disease.  
 
Figure 1: Normal retina in contrast to a retina exhibiting characteristic signs of 
degenerative myopia. Image : Dr James Gilman and The Moran Eye Centre ophthalmology photography 
department. 
Treatment/prevention/slowing progression 
Efforts to reduce the prevalence and progression of myopia could have profound public 
health impact. The focus of intervention in the past has been to correct the refractive error, 
this focus should move towards understanding the underlying pathology and developing 
strategies to (a) prevent the condition developing in the first instance and (b) control the 
rate of progression of myopia once it does develop. Several strategies have been developed 
as a means to try to control myopia progression including the following: (i) optical 
interventions such as multifocal contact lenses, specialised spectacle lenses and 
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orthokeratology; (ii) pharmaceutical interventions such as low dose atropine; (iii) lifestyle 
interventions such as increased outdoor activity. 28 
Ortho-K lenses worn at night flatten the central cornea by forcing the epithelial cells to 
move peripherally, resulting in steepening of the peripheral cornea. This reduces peripheral 
hyperopia, a stimulus for increasing the length of the eye and thereby ameliorates the 
progression of myopia. Multifocal soft contact lenses similarly impact peripheral hyperopia 
and exert a similar controlling effect. 
Another method that has proven successful involves the use of a muscarinic antagonist 
eyedrop such as atropine sulphate to slow the rate of eye growth. A recent meta-analysis 
examining the effectiveness of the different interventions found that the most effective 
intervention was atropine.28 The Myopia Outcomes Study of Atropine In Children (MOSAIC) 
study currently underway in Ireland is using low dose atropine (0.01%) to slow myopia 
progression, while a similar study is also set to commence in the UK (CHAMP-UK). The 
investigation of this low concentration of atropine is particularly important as there is 
evidence to suggest it can slow myopia progression without the visual side effects caused by 
the higher concentrations currently licensed in the UK and Ireland for ophthalmic use. 29  
Time spent outdoors also seems to be protective as evidenced by studies from Singapore 
and Australia.  30, 31 There are also studies from Taiwan showing reduced incidence of 
myopia among children undertaking an intervention called ‘recess outside the classroom’ 
whereby children have increased outdoors exposure. This programme lead to a reduced 
incidence of new myopia in those involved compared to controls. 32 The precise mechanism 
of the effect has yet to be elucidated. It has been postulated from animal studies that an 
increased level of light outdoors may have the effect of increasing retinal dopamine 
production and release, altering gene expression in the retina, which in turn reduces axial 
elongation. 33 There may also be a more straightforward mechanistic explanation involving 
the increased viewing distance and less visually cluttered environment experienced when 
outdoors. Encouraging children to spend more time outdoors is simple, inexpensive and 
likely to benefit their health in general including reducing weight. 
The future 
We now have an understanding of the huge impact environmental factors have on the 
prevalence of myopia. It is necessary to identify those at high risk based on their genetics, 
their geographic location and their behaviours and provide timely intervention with existing 
and emerging treatments. Myopia is a potentially blinding disease. By identifying at risk 
individuals and intervening before they become myopic, eye care practitioners can prevent 
or delay spectacle use, reduce the risk of the myriad of myopic complications and thereby 
improve the patient’s quality of life and positively impact its socio-economic effects. The 
demand for eye services is escalating rapidly. Can society make changes to prevent myopia 
and associated complications? There are many questions that need to be answered and 
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much education to be delivered to key stakeholders so that we can curtail the seemingly 
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